Skip to content

Clinical trials

Completed Phase 3 Lupus Erythematosus, Systemic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lupus Erythematosus, Systemic Phase: Phase 3 Status: Completed Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20032
20061
20071
20082
20103
20114
20122
20131
20141
20151
20184
20191
20201
20212

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed32

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline4
Human Genome Sciences Inc., a GSK Company4
Eli Lilly and Company3
UCB Pharma3
Human Genome Sciences Inc.2
ImmuPharma2
Allergan1
Anthera Pharmaceuticals1
Dr Cipto Mangunkusumo General Hospital1
Genelabs Technologies1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lupus Erythematosus, Systemic32
Autoimmune Diseases11
Immune System Diseases4
Connective Tissue Diseases3
Lupus Nephritis3
Glomerulonephritis2
Arthritis1
Arthritis, Juvenile1
Arthritis, Rheumatoid1
Atherosclerosis1

Trials

Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.